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It has now been a decade since the completion of the 
human genome project, but it is clear that much of its 
biomedical potential is still to be realized. With the 
advent of low-cost, high-throughput sequencing (HTS) 
technologies, there is now an abundance of genomic, 
transcriptomic and epigenomic data. Projects to sequence 
thousands of new human genomes (UK10K project; 
http://www.uk10k.org/) and the genomes of thousands of 
new species (Genome 10K; http://www.genome10k.org/) 
are already underway. The flood of new data is causing 
major shifts in bioinformatics. Only a few years ago 
computational biologists would spend much time and 
effort processing flawed, publicly available data collec-
tions often poorly suited to the tasks at hand. Many of us 
remember human gene number estimates of 100,000 
based upon expressed sequence tag (EST) databases. 
Nowadays everyone seems to be wrestling with large, 
novel datasets; their storage, visualization and analysis, 
and of course attempting to understand what they mean. 
At the same time, we are still in the midst of a chronic 
skills shortage in bioinformatics. One of the organizers of 
the 11th Cold Spring Harbor Laboratory/Wellcome Trust 
conference on Genome Informatics announced that the 
number of participants at this meeting had swelled to an 
all time record of 300. (Apparently the meeting also 
achieved a record proportion of female participants: a 
quarter.) And herein lies the paradox of bioinformatics in 
2011: unparalleled opportunities to produce enormous 
sequencing datasets, matched by a limited number of 
people capable of extracting knowledge from them. This 
quandary is now feeding software development, with the 
aim of providing computational environments to enable 
data analysis by the computationally challenged: in-
variably icon-driven or menu-driven interfaces to 
command line tools. Work describing such developments 
was a major theme at this meeting.
As we get these first glimpses of the universe of human 
genomic variation, much emphasis is on reliable sequence 
variant calling and discovery. There is a more neglected 
question, ‘Which disease variants detected are most 
func tionally meaningful?’ This was addressed by Marc 
Fiume (University of Toronto, Canada), whose talk focused 
on the development of MedSavant (http://genomesavant.
com/medsavant/), a downloadable tool that attempts to 
discriminate disease-causing genetic variants from 
others, via a user-friendly graphical interface. This tool is 
one of many dynamic and interactive platforms that can 
analyze, integrate and visualize data for a wider audience 
of researchers, and are designed to handle the unprece-
dented amount of new data now available. Several new 
applications featured in the meeting, as well as new 
features for more established platforms such as Galaxy 
(http://galaxy.psu.edu/). Jeremy Goecks (Emory Univer-
sity, USA) introduced the new Galaxy Track Browser 
(http://main.g2.bx.psu.edu/), which aims to integrate more 
powerful HTS data analysis tools for real-time manipu-
lations of large datasets in Galaxy, while Ting Wang 
(Washington University, USA) and Christoph Bock (Broad 
Institute, USA) described the new interactive tools Human 
Epigenome Browser (http://epigenomegateway.wustl.edu/) 
and EpiExplorer (http://cosgen.bioinf.mpi-inf.mpg.de/
welcome.php). The Human Epigenome Browser allows 
users to integrate their own data with datasets from the 
NIH Roadmap Epigenomics project (http://www.
roadmapepigenomics.org), one of the current, large-scale 
efforts to comprehensively map the epigenomic land-
scape of human cells. EpiExplorer is a new web tool 
designed to search and integrate epigenomic and 
genomic annotations for analyses of custom datasets 
(again in real time), using tricks from Google search 
algorithms to speed things up. Although all of these tools 
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have different functions, they all have the same goal: to 
make analysis of data more accessible and manageable.
It is not only the genomic complexity of normal cells 
that is emerging, as the focus shifts to include variation 
among cell types and in aberrant states, such as cancers. 
Detecting variants in cancer usually involves mapping 
sequence reads from cancer cells to a reference sequence 
and comparing the results to mapped reads from ‘normal’ 
cell samples, preferably taken from the matched healthy 
tissue of the same individual. As with most assembly 
algorithms, misalignment can be the cause of false variant 
calls and real variants may be missed. Jared Simpson 
(Wellcome Trust Sanger Institute, UK) discussed new 
approaches to the identification of informative variants. 
His methods are based upon direct comparisons of 
normal and tumor samples rather than comparisons to 
the human genome reference sequence. This allows the 
calling of more complex structural variants between 
breast cancer and normal samples, since some classes of 
sequence variation are known to be under-represented in 
the reference sequence. A novel approach to studying 
cancer was described by Mamoru Kato (Cold Spring 
Harbor Laboratories, USA) who has applied population 
genetics to identify copy number variations (CNVs) 
under natural selection in breast cancer cell lines. It 
seems that most observed variations are selectively 
neutral, with a small number subject to selection during 
clonal evolution, and this suggests that such measures 
may be useful in flagging the most important alterations 
in cancer progression.
RNA was also a recurring topic of discussion, with 
several speakers focusing on transcriptomics. Mitchell 
Guttman (Broad Institute, USA) described recent work 
on long intergenic non-coding RNAs (lincRNAs), which 
seem to preferentially associate with chromatin regula-
tory proteins. The functionality of these lincRNAs is 
disputed, as previous knockdown experiments have 
shown few phenotypic consequences. However, knock-
down of ESC-expressed lincRNAs has a strong effect on 
gene expression and pluripotency. This has led to the 
hypothesis that lincRNAs may interact with chromatin 
regulators to maintain the ESC state. No modern dis-
cussion of RNA would be complete without microRNAs, 
and Zhi-Qiang Du (Iowa University, USA) described the 
lineage-specific expansion of microRNA families during 
evolution and their influence on a myriad of complex 
traits such as reproduction and species-specific traits in 
pigs. Of course there are still many areas of RNA biology 
that are poorly understood or unexplored. Jakob Pedersen 
(Aarhus University, Denmark) introduced many new 
families of human regulatory RNA structures to the 
audience. A new comparative method, EvoFam (http://
moma.ki.au.dk/prj/mammals/), has been used to identify 
constrained RNA structural families by their primary 
sequences and secondary structures. Further statistical 
analysis, such as gene ontology (GO) term enrichments, 
was used to generate hypotheses about potential func-
tions for the new families identified.
Steven Salzberg (Johns Hopkins University School of 
Medicine, USA) reported the (only slightly exaggerated) 
mantra of genomics in 2011, ‘Sequencing is free - so let’s 
sequence everything’. However, sequencing everything 
introduces a lot of complexity to genome assembly. We 
lack an accurate reference genome for most species, and 
so there is enormous demand for new short-read assembly 
algorithms that are fast and memory efficient. The rapid 
evolution of sequencing technology means that older 
assemblers, used on longer sequence reads, are no longer 
appropriate. It is therefore important to continually 
develop and reassess assembling methods, especially 
with a view to ambitious projects such as the Genome 
10K project, which aims to sequence and assemble 
10,000 vertebrate genomes by 2015.
With several new assembler methods now available, 
there is considerable interest in comparing them to 
investi gate which assembler is most appropriate for a 
parti cular application. Benedict Paten (University of 
California, Santa Cruz, USA) described the Assemblathon 
competition (http://www.assemblathon.org/), which com-
pared several new assembly methods on current 
sequencing datasets. A total of 17 teams participated in 
the contest to assemble a complex genome from simu-
lated data to examine, among other factors, their levels of 
coverage and contiguity. Salzberg presented the second 
comparison study: GAGE (Genome Assembly Gold-
Standard Evaluations; http://gage.cbcb.umd.edu). This 
project compared several different assembly algorithms 
on sequencing datasets from a variety of species, includ-
ing bacteria, invertebrates and vertebrates. They aimed to 
guide researchers planning sequencing projects in the 
extent of coverage needed, which assembler and para-
meters were most appropriate for their experimental 
designs, and species of interest. Both GAGE and 
Assemblathon highlight the large degree of disagreement 
between the different assemblers used, and suggest that 
genome assembly is far from a resolved issue. GAGE 
identified the assembler ALLPATHS-LG (http://www.
broadinstitute.org/software/allpaths-lg/blog/) as a clear 
winner over all species that were tested, while the 
Assemblathon project identified SOAPdenovo (http://
soap.genomics.org.cn/soapdenovo.html) as the best 
assembler, having the best overall score and highest 
coverage.
Keynote speaker Evan Eichler (Washington University, 
USA) discussed the occurrence of CNVs in the human 
genome; this is remarkably common (each of us carry 
several hundred variations greater than 5 kb long) and 
has been linked to a variety of diseases such as psoriasis 
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and autism. In spite of this, only a small proportion of 
this variation is assayed by widely used SNP genotyping 
platforms. The human reference genome sequence neces-
sarily provides an incomplete picture in regions harbor-
ing CNVs, as assembly algorithms will often collapse 
multiply duplicated regions into a single, smaller copy. 
Eichler described his and others’ laborious efforts to fill 
these gaps using novel approaches. Longer sequencing 
reads are needed to reliably incorporate CNVs and 
repeats into the reference genome, and de novo human 
genome assemblies can be significantly shorter in length 
than the reference genome because of these missing 
sections. However, long reads are more costly to produce. 
In order to study gene CNV, Eichler has used fosmids, a 
sequencing vector capable of containing 40 kb genomic 
DNA, to investigate these previously inaccessible parts of 
the human genome. This in-depth re-sequencing of some 
loci has revealed exciting new regions subject to CNVs 
between human populations not observed in the refer-
ence sequence, containing genes involved in immunity 
and brain development. Eichler finished with a plea for a 
high-quality, high-coverage reference genome for every 
biomedically important species.
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